Press Release: Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Precision Neurodegenerative Disease Market, Global, 2024-2028" report has been added to ResearchAndMarkets.com's offering. The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique…
Press Release: Precision Neurodegenerative Disease Global Market Report 2024-2028: Key Growth Opportunities in GLP-1 RA and Insulin for AD and PD Patients and Neurotech-based Precision Therapies - Newscast
Fri, 14 Mar 2025 08:19:04 GMT In Nature Neuroscience, UConn School of Medicine researchers have revealed a new scientific clue that could unlock the key cellular pathway leading to devastating neurodegenerative diseases like ...
Thu, 13 Mar 2025 06:22:00 GMT AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today reported results for the full year ended December 31, ...
Mon, 03 Mar 2025 23:00:00 GMT Lausanne, Switzerland, March 4, 2025 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative ... does not constitute a part of, ...
Mon, 03 Mar 2025 04:15:00 GMT However, the dysfunction of SGs has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). While their role in ...
Mon, 24 Feb 2025 12:37:00 GMT LOS ANGELES, Feb. 24, 2025 /PRNewswire/ -- California has introduced a new initiative to advance critical research for ALS and related neurodegenerative diseases like Parkinson's, Alzeheimer's ...
